Skip to content

Comparing Two Anaesthesia Gases To Understand Their Effect On Body Temperature During Surgery.

Comparison Of Sevoflurane And Isoflurane On Core And Peripheral Body Temperatures During General Anaesthesia: A Randomised Clinical Study - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105255
Enrollment
50
Registered
2026-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: SEVOFLURANE: Sevoflurane is a volatile inhalational anaesthetic agent administered via a calibrated vaporizer during general anaesthesia of duration of surgery 1 to 3 hours. Following s

Sponsors

CHRI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 to 65 years ASA physical status one or two Undergoing elective surgeries under general anaesthesia of duration 1 to 3 hours

Exclusion criteria

Exclusion criteria: patients refusal to surgery febrile illness or hypothermia at baseline peripheral vascular disease endocrine disorder affecting thermoregulation BMI more than 35 emergency surgeriesWomen who are in menstrual phase of the menstruation cycle Cardiac ,renal , hepatic disease

Design outcomes

Primary

MeasureTime frame
To compare the core body temperature intra operatively between Sevoflurane versus Isoflurane. Timepoint: preinduction start of anaesthesia every 15 minutes of surgery end of surgery 45 minutes after surgery

Secondary

MeasureTime frame
To compare the core to peripheral temperature gradient between Sevoflurane versus Isoflurane during general anaesthesia.Timepoint: pre induction of anaesthesia baseline start of anaesthesia every 15 minutes until completion of surgery 45 minutes after surgery

Countries

India

Contacts

Public ContactDhivya N

DR.VIJAY NARAYANAN S

nagadhivya2016@gmail.com9976540335

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026